BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 37052748)

  • 1. Clinicopathologic analysis of pineal parenchymal tumors of intermediate differentiation: a multi-institutional cohort study by the Kyushu Neuro-Oncology Study Group.
    Yamashita S; Takeshima H; Hata N; Uchida H; Shinojima N; Yokogami K; Nakano Y; Sakata K; Fudaba H; Enomoto T; Nakahara Y; Ujifuku K; Sugawara K; Iwaki T; Sangatsuda Y; Yoshimoto K; Hanaya R; Mukasa A; Suzuki K; Yamamoto J; Negoto T; Nakamura H; Momii Y; Fujiki M; Abe H; Masuoka J; Abe T; Matsuo T; Ishiuchi S;
    J Neurooncol; 2023 Apr; 162(2):425-433. PubMed ID: 37052748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognosticating survival of pineal parenchymal tumors of intermediate differentiation (PPTID) by grade.
    Lu VM; Luther EM; Eichberg DG; Morell AA; Shah AH; Komotar RJ; Ivan ME
    J Neurooncol; 2021 Nov; 155(2):165-172. PubMed ID: 34606044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic study of pineal parenchymal tumors of intermediate differentiation.
    Ito T; Kanno H; Sato K; Oikawa M; Ozaki Y; Nakamura H; Terasaka S; Kobayashi H; Houkin K; Hatanaka K; Murata J; Tanaka S
    World Neurosurg; 2014; 81(5-6):783-9. PubMed ID: 23396072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histopathologic review of pineal parenchymal tumors identifies novel morphologic subtypes and prognostic factors for outcome.
    Raleigh DR; Solomon DA; Lloyd SA; Lazar A; Garcia MA; Sneed PK; Clarke JL; McDermott MW; Berger MS; Tihan T; Haas-Kogan DA
    Neuro Oncol; 2017 Jan; 19(1):78-88. PubMed ID: 27282397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular heterogeneity of pineal parenchymal tumors: a consensus study.
    Liu APY; Li BK; Pfaff E; Gudenas B; Vasiljevic A; Orr BA; Dufour C; Snuderl M; Karajannis MA; Rosenblum MK; Hwang EI; Ng HK; Hansford JR; Szathmari A; Faure-Conter C; Merchant TE; Levine M; Bouvier N; von Hoff K; Mynarek M; Rutkowski S; Sahm F; Kool M; Hawkins C; Onar-Thomas A; Robinson GW; Gajjar A; Pfister SM; Bouffet E; Northcott PA; Jones DTW; Huang A
    Acta Neuropathol; 2021 May; 141(5):771-785. PubMed ID: 33619588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Features of Pineal Parenchymal Tumors of Intermediate Differentiation (PPTID): A Single-Institution Series.
    Kunigelis KE; Kleinschmidt-DeMasters BK; Youssef AS; Lillehei KO; Ormond DR
    World Neurosurg; 2021 Nov; 155():e229-e235. PubMed ID: 34418607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pineal parenchymal tumor of intermediate differentiation: a systematic review and contemporary management of 389 cases reported during the last two decades.
    Takase H; Tanoshima R; Singla N; Nakamura Y; Yamamoto T
    Neurosurg Rev; 2022 Apr; 45(2):1135-1155. PubMed ID: 34668090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spinal Dissemination of Pineal Parenchymal Tumors of Intermediate Differentiation Over 10 Years After Initial Treatment: A Case Report.
    Miyazaki A; Makino K; Shinojima N; Yamashita S; Mikami Y; Mukasa A
    Cureus; 2024 Mar; 16(3):e57147. PubMed ID: 38681294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical experience and outcomes in patients with pineal parenchymal tumor of intermediate differentiation (PPTID): a single-institution analysis.
    Webb M; Johnson DR; Mahajan A; Brown P; Neth B; Kizilbash SH; Sener U
    J Neurooncol; 2022 Nov; 160(2):527-534. PubMed ID: 36301435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of proliferative marker index and KBTBD4 mutation in the pathological diagnosis of pineal parenchymal tumors.
    Uchida E; Sasaki A; Shirahata M; Suzuki T; Adachi JI; Mishima K; Yasuda M; Fujimaki T; Ichimura K; Nishikawa R
    Brain Tumor Pathol; 2022 Jul; 39(3):130-138. PubMed ID: 35000018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of care and survival outcomes in patients with pineal parenchymal tumor of intermediate differentiation: An individual patient data analysis.
    Mallick S; Benson R; Rath GK
    Radiother Oncol; 2016 Nov; 121(2):204-208. PubMed ID: 27865543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant Pineal Parenchymal Tumors in Adults: A National Cancer Database Analysis.
    Chalif EJ; Murray RD; Mozaffari K; Chillakuru YR; Shim T; Monfared A; Sherman JH
    Neurosurgery; 2022 Jun; 90(6):807-815. PubMed ID: 35311743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pineal Parenchymal Tumor of Intermediate Differentiation (PPTID) and Papillary Tumor of Pineal Region (PTPR): A Review.
    Sadashiva N; Deora H; Arumalla K; Rao S; Saini J; Shukla D; Santosh V
    Neurol India; 2021; 69(5):1153-1164. PubMed ID: 34747779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent KBTBD4 small in-frame insertions and absence of DROSHA deletion or DICER1 mutation differentiate pineal parenchymal tumor of intermediate differentiation (PPTID) from pineoblastoma.
    Lee JC; Mazor T; Lao R; Wan E; Diallo AB; Hill NS; Thangaraj N; Wendelsdorf K; Samuel D; Kline CN; Banerjee A; Auguste K; Raffel C; Gupta N; Berger M; Raleigh DR; Shai A; Phillips JJ; Bollen AW; Tihan T; Perry A; Costello J; Solomon DA
    Acta Neuropathol; 2019 May; 137(5):851-854. PubMed ID: 30877433
    [No Abstract]   [Full Text] [Related]  

  • 15. Integrated Genomic Characterization of a Pineal Parenchymal Tumor of Intermediate Differentiation.
    Kang YJ; Bi WL; Dubuc AM; Martineau L; Ligon AH; Berkowitz AL; Aizer AA; Lee EQ; Ligon KL; Ramkissoon SH; Dunn IF
    World Neurosurg; 2016 Jan; 85():96-105. PubMed ID: 26226092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary pineal tumors - Unraveling histological challenges and certain clinical myths.
    Verma A; Epari S; Bakiratharajan D; Sahay A; Goel N; Chinnaswamy G; Shetty P; Moiyadi A; Goel A; Gupta T; Jalali R
    Neurol India; 2019; 67(2):491-502. PubMed ID: 31085866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic Prognostic Factors of Pineal Parenchymal Tumor of Intermediate Differentiation.
    Chatterjee D; Lath K; Singla N; Kumar N; Radotra BD
    Appl Immunohistochem Mol Morphol; 2019 Mar; 27(3):210-215. PubMed ID: 28800009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pineal parenchymal tumor of intermediate differentiation.
    Patil M; Karandikar M
    Indian J Pathol Microbiol; 2015; 58(4):540-2. PubMed ID: 26549088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic strategy for pineal parenchymal tumor of intermediate differentiation (PPTID): case report of PPTID with malignant transformation to pineocytoma with leptomeningeal dissemination 6 years after surgery.
    Bando T; Ueno Y; Shinoda N; Imai Y; Ichikawa K; Kuramoto Y; Kuroyama T; Shimo D; Mikami K; Hori S; Matsumoto M; Hirai O
    J Neurosurg; 2018 Jul; 130(6):2009-2015. PubMed ID: 30028263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pineal parenchymal tumours of intermediate differentiation - An evidence-based review of a new pathological entity.
    Amato-Watkins AC; Lammie A; Hayhurst C; Leach P
    Br J Neurosurg; 2016; 30(1):11-5. PubMed ID: 26571134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.